4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)- cas no:3485-14-1

Name4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-
CAS3485-14-1
Synonyms4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo- (7CI,8CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2a,5a,6b)]-; (1-Aminocyclohexyl)penicillin; 6-(1-Aminocyclohexanecarboxamido)penicillanicacid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid;Aminocyclohexylpenicillin; Calthor; Ciclacillin; Ciclacillum; Citosarin;Cyclacillin; Cyclapen; NSC 88789; Penicillin, (aminocyclohexyl)-; Syngacillin;Ultracillin; Vastcillin; Vatracin; Vipicil; Wy 4508; Wyvital
EINECS(EC#)222-470-8
Molecular FormulaC15H23 N3 O4 S
Molecular Weight341.47

refractive index1.631

Safety

Moderately toxic by ingestion and other routes. Human systemic effects by ingestion: dermatitis and diarrhea. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of SO_x and NO_x.

1.		orl-hmn TDLo:210 mg/kg/7D-I:GIT,SKN		CHTHBK    Chemotherapy. 22 (1976),154.
2.		orl-rat LD50:5010 mg/kg		CHTHBK    Chemotherapy. 22 (1976),154.
3.		ipr-rat LD50:5010 mg/kg		CHTHBK    Chemotherapy. 22 (1976),154.
4.		scu-rat LD50:6500 mg/kg		TAKHAA    Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. 29 (1970),117.
5.		orl-mus LD50:5010 mg/kg		CHTHBK    Chemotherapy. 22 (1976),154.
6.		ipr-mus LD50:3776 mg/kg		CHTHBK    Chemotherapy. 22 (1976),154.
7.		scu-mus LD50:7500 mg/kg		TAKHAA    Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. 29 (1970),117.
8.		orl-dog LD50:2500 mg/kg		CHTHBK    Chemotherapy. 22 (1976),154.